论文部分内容阅读
我们评估18F-FDG PET/CT对于乳腺癌病人新辅助化疗(NACT)2个周期后反应的评价作用。23例女性局部进展性乳腺癌病人纳入本研究。NACT2个周期后,根据临床检查、CT和18F-FDG PET/CT评价早期反应。
We evaluated the evaluation of 18F-FDG PET / CT after two cycles of neoadjuvant chemotherapy (NACT) in patients with breast cancer. Twenty-three women with locally advanced breast cancer were included in this study. After 2 cycles of NACT, early responses were evaluated according to clinical examination, CT and 18F-FDG PET / CT.